MYCN and glioma: Likewise, miR-146b [104], miR-124a [105], and miR-34a [106] were introduced into glioma cells from transfected hBMSC-derived EVs and abrogated glioma growth by decreasing EGFR and NF-κB protein, silencing FOXA2 and downregulating MYCN, respectively.